Four High-Impact Publications, One Powerful Platform — Rocgene Archimed X6
Cutting-Edge Research Powered by Rocgene Archimed X6
Recent studies by leading researchers have utilized the Rocgene Archimed X6, a next- generation analytical platform supporting advances in biomedical research. Recent publications have showcased its versatility across diverse research frontiers.
| Title | Journal | Latest Impact Factor |
| Functionalized Macrophage Exosomes with Panobinostat and PPM1D-siRNA for Diffuse Intrinsic Pontine Gliomas Therapy. Click Here | Advanced Science | 14.1 |
| Scutellarin activates IDH1 to exert antitumor effects in hepatocellular carcinoma progression. Click Here | Cell Death Disease | 9.6 |
| ZNF281 inhibits mitochondrial biogenesis to facilitate metastasis of hepatocellular carcinoma. Click Here | Cell Death Disease | 9.6 |
| UHMK1‑dependent phosphorylation of Cajal body protein coilin alters 5‑FU sensitivity in colon cancer cells. Click Here | Cell Communication and Signalling | 8.9 |
Each of these studies exemplifies how the Archimed X6 empowers precision, reproducibility, and speed in complex biological analyses.